Search
Menu
Home
HTB
2015
June
HTB
June 2015
Contents
Editorial
May/June 2015: Volume 16 Number 5/6
In memory
Remembering Professor Martin Fisher
Treatment alerts
Early START results recommend ART for all study participants: starting HIV meds when the CD4 count is above 500 reduces AIDS-related events
Conference reports
21st Annual BHIVA Conference, 21-24 April 2015, Brighton
BHIVA pregnancy audit 2013 to 2014
Transmitted drug resistance in HIV positive pregnant women
Primary HIV infection and early use of ART
Rectal STIs and viral load in HIV positive men on and off ART
Impact of age and HIV on use of non-HIV meds: early results on health care use in the POPPY study
Other short reports from BHIVA:
2015 Conference on Retroviruses and Opportunistic Infections (CROI), 23-26 February 2015, Seattle
Elvitegravir in children and adolescents
PK of ARVs in pregnancy: rilpivirine, etravirine and raltegravir
HIV and cardiovascular disease
5th International Workshop on HIV & Women , 21-22 February 2015, Seattle, Washington
Pharmacokinetics in pregnancy: darunavir/r and etravirine
Low prolactin and high 20alpha-HSD might contribute to ART-associated progesterone deficits in pregnancy
Pregnancy rates among women using ART and hormonal contraceptives in Kenya
Adolescents at increased risk of vertical transmission and poor pregnancy outcome in South Africa
Gender difference in virological response to ART
Antiretrovirals
Generic dolutegravir submitted to FDA for tentative approval
EMA approves coformulated atazanavir/cobicistat
Dual F/TAF formulation under evaluation by EMA
Treatment access
Lopinavir/ritonavir pellets tentatively approved by the FDA
Sofosbuvir access: new patent challenges to sofosbuvir
Guidelines
US guidelines shift to integrase-based combinations for first-line treatment (2015): Atripla relegated due to side effects
EACS guidelines (2015): translations in 11 languages now available online
Recommendations for management of bone health in people living with HIV
TB coinfection
New clinical trial for extensively drug resistant TB (XDR-TB)
MSF report and call to action: Promising new TB drugs are not reaching patients
HIV prevention and transmission
Methmephangee – ChemSex vs recreational drug use: a proposed definition for health workers
Basic science and immunology
Timing of very early ART to limit early HIV-related mucosal dysfunction
Broad CD8 T cell responses are required to overcome dominance of CTL escape in the latent HIV reservoir
Broadly neutralising antibody suppresses HIV in clinical trial
Other news
WHO statement for public disclosure of clinical trial results
PDFs
May/June 2015: Volume 16 Number 5/6
HTB RSS
Early access
Updated treatment guides
5 December 2024
All early access reports
Current issues
December 2024
November 2024
October 2024
Back issues
Special report
Unheard: The medical practice of silencing – by Dr Rageshri Dhairyawan
9 November 2024
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate